uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Expression of CYP4F12 in gastrointestinal and urogenital epithelia
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Surgical Sciences. Urologi. (Urologi)
Show others and affiliations
2004 (English)In: Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, Vol. 94, no 4, 177-83 p.Article in journal (Other academic) Published
Abstract [en]

Cytochrome P450 4F12 (CYP4F12) was originally cloned from human liver and small intestine. CYP4F12 can oxidize arachidonic acid, two stable prostaglandin H2 analogues, and an antihistamine, ebastine, but the tissue distribution and catalytic properties of CYP4F12 have not been fully investigated. An antipeptide polyclonal antibody was raised against the C-terminal of CYP4F12 (PLNVGLQ), evaluated by Western blot analysis and used for immunohistological analysis of 50 human tissues. Western blot analysis of recombinant CYP4F12, expressed in yeast, and microsomal proteins from adult and foetal liver, kidney, placenta at term, seminal vesicles, the prostate gland and purified prostasomes showed that the polyclonal antibody detected a protein of the expected size, approximately 60 kDa. CYP4F12 mRNA could be detected in seminal vesicles and prostate gland by reverse transcription-PCR. Prominent CYP4F12 immunoreactivity occurred, inter alia, in the epithelial cells of the gastrointestinal tract (stomach, small intestine, and colon), collecting tubules, transitional epithelium, ovarian follicles, the endothelium of microvessels of placental villi (first trimester), and epidermis. We screened recombinant CYP4F12 for catalytic activity. Arachidonic acid (20:4n-6) was hydroxylated at C18 and laurate at C11, but significant amounts of metabolites of 18:2n-6, 20:3n-9, 20:5n-3, 22:5n-6, and some prostaglandins could not be detected. We conclude that CYP4F12 is widely distributed in gastrointestinal and urogenital epithelia and exhibits a narrow substrate specificity.

Place, publisher, year, edition, pages
2004. Vol. 94, no 4, 177-83 p.
Keyword [en]
Aryl Hydrocarbon Hydroxylases/*biosynthesis/genetics, Catalysis, Comparative Study, Eicosanoids/metabolism, Epidermis/metabolism, Epithelium/metabolism, Fatty Acids/metabolism, Female, Humans, In Vitro, Intestinal Mucosa/*metabolism, Intestine; Small/metabolism, Kidney/metabolism, Liver/metabolism, Male, Mixed Function Oxygenases/*biosynthesis/genetics, Organ Specificity, Placenta/metabolism, Pregnancy, Prostate/metabolism, RNA; Messenger/biosynthesis, Research Support; Non-U.S. Gov't, Reverse Transcriptase Polymerase Chain Reaction, Seminal Vesicles/metabolism, Substrate Specificity, Urogenital System/*metabolism
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-73686DOI: 10.1111/j.1742-7843.2004.pto940404.xPubMedID: 15078342OAI: oai:DiVA.org:uu-73686DiVA: diva2:101596
Available from: 2005-06-14 Created: 2005-06-14Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15078342&dopt=Citation
By organisation
Department of Surgical Sciences
In the same journal
Basic & Clinical Pharmacology & Toxicology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 113 hits
ReferencesLink to record
Permanent link

Direct link